# Boston University CCCR

> **NIH NIH P30** · BOSTON UNIVERSITY MEDICAL CAMPUS · 2020 · $725,375

## Abstract

OVERALL
ABSTRACT
The Boston University CCCR will serve as a central resource for clinical research focused mostly on the most
common musculoskeletal disorders, osteoarthritis and gout and will also provide research resources for
investigator based research in scleroderma, spondyloarthritis, musculoskeletal pain and osteoporosis. Center
grant funding has supported 30-35 papers annually in peer reviewed journals, most in the leading arthritis
journals and some in leading general medical journals. This center has trained many of the leading clinical
researchers in rheumatology throughout the US and internationally, and many of these former trainees have
active collaborations with the center.
We will include a broad research community and a core group of faculty in this CCCR. The research community's
ready access to core faculty and to the sophisticated research methods and assistance they provide will enhance
the clinical and translational research of the community and will increase collaborative opportunities for the core
faculty and the community. The CCCR updates BU's historical focus on epidemiologic methods to include new
approaches to causal inference and adds new methods in machine learning and mobile health.
The Research and Evaluation Support Core Unit (RESCU) is the focal point of this CCCR. A key feature is the
weekly research (RESCU meetings in which ongoing and proposed research projects are critically evaluated.
This feature ensures frequent interactions between clinician researchers, epidemiologists and biostatisticians
who are the core members of the CCCR. The RESCU core unit has provided critical support for other Center
grants related to rheumatic and arthritic disorders at Boston University, three current R01/U01's; five current NIH
K awards (one K24, 3 K23's, one K01), an R03, an NIH trial planning grant (U34), and multiple ACR RRF awards.
The overall goal of this center is to carry out and disseminate high-level clinical research informed both by state
of the art clinical research methods and by clinical and biological scientific discoveries. Ultimately, we aim either
to prevent the diseases we are studying or to improve the lives of those living with the diseases.

## Key facts

- **NIH application ID:** 10017004
- **Project number:** 5P30AR072571-02
- **Recipient organization:** BOSTON UNIVERSITY MEDICAL CAMPUS
- **Principal Investigator:** DAVID Tobin FELSON
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $725,375
- **Award type:** 5
- **Project period:** 2019-09-11 → 2024-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10017004

## Citation

> US National Institutes of Health, RePORTER application 10017004, Boston University CCCR (5P30AR072571-02). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10017004. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*